Royalty Pharma plc (RPRX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $2.49B | -10.1% |
| 2024 | $2.77B | -7.3% |
| 2023 | $2.99B | +39.4% |
| 2022 | $2.14B | +6.3% |
| 2021 | $2.02B | -0.8% |
| 2020 | $2.03B | +22.0% |
| 2019 | $1.67B | +3.0% |
| 2018 | $1.62B | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $2.49B | -10.1% |
| 2024 | $2.77B | -7.3% |
| 2023 | $2.99B | +39.4% |
| 2022 | $2.14B | +6.3% |
| 2021 | $2.02B | -0.8% |
| 2020 | $2.03B | +22.0% |
| 2019 | $1.67B | +3.0% |
| 2018 | $1.62B | — |